Study finds biomarker p-tau217 strongly linked to future dementia risk
Dr. Eric B. Larson, a report contributor, answers questions about reducing risks, disparities, and threats from COVID-19.
$40.5M NIH-funded project aims to pinpoint cells at root of brain disease—and new therapeutic targets.
Dr. Sascha Dublin explores what this reassuring finding from the Kaiser Permanente-UW ACT study means for patients with acid reflux.
